Basic Information
| LncRNA/CircRNA Name | TRERNA1 |
| Synonyms | NA |
| Region | GRCh38_20:50040716-50041504 |
| Ensemble | ENSG00000231265 |
| Refseq | NR_051976 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qRT-PCR |
| Sample | NSCLC tissues,cell Lines |
| Expression Pattern | up-regulated |
| Function Description | LncRNA TRERNA1 was up-regulated both in NSCLC tissues and cell lines. Its level was associated with pathological stage and poor prognosis in NSCLC. In addition, lncRNA TRERNA1 could promote the malignant progression of NSCLC via modulating FOXL1. |
| Pubmed ID | 32096153 |
| Year | 2020 |
| Title | LncRNA TRERNA1 promotes malignant progression of NSCLC through targeting FOXL1 |
External Links
| Links for TRERNA1 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |